Technology Assessment at SickKids (TASK)
Technology Assessment at SickKids (TASK) was created in response to the growing interest in Health Technology Assessment (HTA) and health economic evaluation at The Hospital for Sick Children in Toronto both from an institutional perspective, and from a researcher's perspective.
TASK aims to assist the hospital in making challenging purchase decisions by producing HTA reports on topics of interest.
TASK also provides assistance to researchers who wish to undertake economic evaluations of health technologies.
- HTA for decision support
- Research to improve and expand HTA methodology
- Training
- Partnership and linkages
- Knowledge transfer
The Team
Wendy Ungar, MSc, PhD
Senior Scientist, Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto
Associate Professor, Health Policy, Management and Evaluation, University of Toronto
As Director of TASK, Dr. Ungar's primary research interests include health economic methods research, medication cost-sharing and health outcomes in children with asthma and health technology assessment of interventions and programs for children.
For more information, please visit Dr. Ungar's profile. »»
Dean Regier, PhD
Research Associate, The Hospital for Sick Children, Toronto
Dr. Regier joined TASK as a Research Associate in February 2010. He received his MA in economics from Carleton University, Ottawa, in 2003 and his PhD in Health Economics from the University of Aberdeen, Aberdeen, Scotland, in 2008. His doctoral dissertation was, Discrete choice experiments informing cost benefit analysis: a Bayesian approach with an application to genetic testing. Dr. Regier worked as a health economist at the Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, and more recently was a Fulford Junior Research Fellow, Somerville College, University of Oxford, a Senior Health Economist at the National Perinatal Epidemiology Unit (NPEU), University of Oxford, and a Research Associate at the Health Economics Research Centre, University of Oxford, Oxford, England.
Projects
Concluded
- Caspofungin in the empiric treatment of febrile neutropenia in paediatric patients: A comparison with conventional and liposomal amphotericin B.
- The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis.
- A systematic review of orchidopexy in paediatrics. A report prepared for the Canadian Paediatric Surgical Wait Times Project.
- Health technology assessment of thiopurine methyltransferase testing for guiding 6-mercaptopurine doses in paediatric patients with acute lymphoblastic leukemia.
Ongoing
- A cost-effectiveness analysis of maternal genotyping to guide treatment for postpartum pain and avert infant adverse events
- Willingness to pay for biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
 The following reports are available in Acrobat format.
Caspofungin in the empiric treatment of febrile neutropenia in paediatric patients: A comparison with conventional and liposomal amphotericin B
The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis.
Health technology assessment of thiopurine methyltransferase testing for guiding 6-mercaptopurine doses in paediatric patients with acute lymphoblastic leukemia
Contact Us
Address:
Wendy Ungar / Dean Regier
The Hospital for Sick Children
Child Health Evaluative Sciences
555 University Avenue
Toronto, Ontario
M5G 1X8
Canada
Wendy Ungar, MSc, PhD
Phone: 416-813-8519
wendy.ungar@sickkids.ca
Dean Regier, MA, PhD
Phone: 416-813-7654 ext. 4858
dean.regier@sickkids.ca
Fax: 416-813-5979
|
